• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Modular Medical Inc.

    3/1/24 3:48:41 PM ET
    $MODD
    Medical/Dental Instruments
    Health Care
    Get the next $MODD alert in real time by email
    SC 13G 1 modd_30124.htm 683 CAPITAL MANAGEMENT, LLC modd_30124.htm
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    SCHEDULE 13G
    Under the Securities Exchange Act of 1934
    Modular Medical, Inc.
    (Name of Issuer)
    Common Stock, $0.001 par value per share
    (Title of Class of Securities)
    60785L207
    (CUSIP Number)
    February 16, 2024
    (Date of Event which Requires Filing of this Statement)
    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    [   ] Rule 13d-1(b)
    [X] Rule 13d-1(c)
    [   ] Rule 13d-1(d)
    * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see Instructions).
    CUSIP No.: 60785L207
           
    1
    NAME OF REPORTING PERSON
    683 Capital Management, LLC
    I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a) [   ]
    (b) [   ]
    3 SEC USE ONLY
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
    Delaware
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5
    SOLE VOTING POWER
    0
    6
    SHARED VOTING POWER
    2,211,999
    7
    SOLE DISPOSITIVE POWER
    0
    8
    SHARED DISPOSITIVE POWER
    2,211,999
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    2,211,099
    10
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
    [   ]
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
    6.99%
    12
    TYPE OF REPORTING PERSON
    IA
    CUSIP No.: 60785L207
           
    1
    NAME OF REPORTING PERSON
    683 Capital Partners, LP
    I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a) [   ]
    (b) [   ]
    3 SEC USE ONLY
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
    Delaware
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5
    SOLE VOTING POWER
    0
    6
    SHARED VOTING POWER
    2,211,999
    7
    SOLE DISPOSITIVE POWER
    0
    8
    SHARED DISPOSITIVE POWER
    2,211,999
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    2,211,999
    10
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
    [   ]
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
    6.99%
    12
    TYPE OF REPORTING PERSON
    PN
    CUSIP No.: 60785L207
           
    1
    NAME OF REPORTING PERSON
    Ari Zweiman
    I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a) [   ]
    (b) [   ]
    3 SEC USE ONLY
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
    United States of America
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5
    SOLE VOTING POWER
    0
    6
    SHARED VOTING POWER
    2,211,999
    7
    SOLE DISPOSITIVE POWER
    0
    8
    SHARED DISPOSITIVE POWER
    2,211,999
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    2,211,999
    10
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
    [   ]
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
    6.99%
    12
    TYPE OF REPORTING PERSON
    IN
    CUSIP No.: 60785L207
    ITEM 1(a). NAME OF ISSUER:
    Modular Medical, Inc.
    ITEM 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
    10740 Thornmint Road San Diego, California 92127
    ITEM 2(a). NAME OF PERSON FILING:
    683 Capital Management, LLC
    683 Capital Partners, LP
    Ari Zweiman
    ITEM 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:
    The principal business address for each of the Reporting Persons is 1700 Broadway, Suite 4200, New York, NY 10019.
    ITEM 2(c). CITIZENSHIP:
    683 Capital Management, LLC is a Delaware limited liability company. 683 Capital Partners, LP is a Delaware limited partnership. Ari Zweiman is a citizen of the United States.

    ITEM 2(d). TITLE OF CLASS OF SECURITIES:
    Common Stock, $0.001 par value per share
    ITEM 2(e). CUSIP NUMBER:
    60785L207
    ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO SECTION 240.13d-1(b), or 13d-2(b) or (c) CHECK WHETHER THE PERSON FILING IS A:
    (a)
    [ ]
    Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78c);
    (b)
    [ ]
    Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)
    [ ]
    Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)
    [ ]
    Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8);
    (e)
    [ ]
    An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E);
    (f)
    [ ]
    An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F);
    (g)
    [ ]
    A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G);
    (h)
    [ ]
    A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)
    [ ]
    A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)
    [ ]
    A non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J);
    (k)
    [ ]
    Group, in accordance with 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with 240.13d1(b)(1)(ii)(J), please specify the type of institution:
    ITEM 4. OWNERSHIP
    (a) Amount beneficially owned:
    As of February 16, 2024, 683 Capital Partners, LP beneficially owned 1,570,000 shares of Common Stock and warrants to purchase 641,999 shares of Common Stock which are currently exercisable.

    683 Capital Management, LLC as the investment manager of 683 Capital Partners, LP may be deemed to have beneficially owned the 1,570,000 shares of Common Stock and warrants to purchase 641,999 shares of Common Stock beneficially owned by 683 Capital Partners, LP.

    Ari Zweiman as the Managing Member of 683 Capital Management, LLC may be deemed to have beneficially owned the 1,570,000 shares of Common Stock and warrants to purchase 641,999 shares of Common Stock beneficially owned by 683 Capital Management LLC.
    (b) Percent of class:
    The following percentages are based on 30,989,968 shares of Common Stock reported as outstanding as of following the closing of the public offering of 9,090,910 shares of Common Stock as disclosed in the Issuers prospectus supplement filed pursuant to Rule 424(b)(5) filed with the SEC on February 20, 2024 plus 641,999 shares of Common Stock issuable upon exercise of currently exercisable warrants held by the Reporting Persons.

    As of February 16, 2024, each of the Reporting Persons may be deemed to have beneficially owned approximately 6.99% of the outstanding shares of Common Stock.
    (c) Number of shares as to which the person has:
    (i) sole power to vote or to direct the vote:
    See Cover Pages Items 5-9
    (ii) shared power to vote or to direct the vote:
    See Cover Pages Items 5-9
    (iii) sole power to dispose or direct the disposition of:
    See Cover Pages Items 5-9
    (iv) shared power to dispose or to direct the disposition of:
    See Cover Pages Items 5-9
    ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS:
    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ ].
    ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON:
    Not applicable.
    ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY:
    Not applicable.
    ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP:
    See Exhibit A.
    ITEM 9. NOTICE OF DISSOLUTION OF GROUP:
    Not Applicable.
    ITEM 10. CERTIFICATION:
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
    CUSIP No.: 60785L207
    SIGNATURE
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
    March 01 2024
    683 Capital Management, LLC
    By:
    /s/ Ari Zweiman
    Name:
    Ari Zweiman
    Title:
    Managing Member
    March 01 2024
    683 Capital Partners, LP
    By:
    /s/ Ari Zweiman
    Name:
    Ari Zweiman
    Title:
    Authorized Person
    March 01 2024
    Ari Zweiman
    By:
    /s/Ari Zweiman
    Name:
    Ari Zweiman
    Title:
    Attention — Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001).
    CUSIP No.: 60785L207
    JOINT FILING AGREEMENT

    The undersigned hereby agree that the statement on Schedule 13G with respect to the Common Shares of Modular Medical, Inc. dated as of March 1, 2024, is, and any further amendments thereto signed by each of the undersigned shall be, filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(2) under the Securities Exchange Act of 1934, as amended.

    Dated: March 1, 2024

    683 CAPITAL MANAGEMENT, LLC

    By: /s/ Ari Zweiman
    Ari Zweiman,
    Managing Member

    683 CAPITAL PARTNERS, LP

    By: /s/ Ari Zweiman
    Ari Zweiman,
    Authorized Person

    /s/ Ari Zweiman
    Ari Zweiman
    Get the next $MODD alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MODD

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $MODD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Modular Medical Announces Licensing and Partnership Agreement With Nudge BG

    -Modular Medical will collaborate with Nudge BG to bring to market an adaptive full closed loop Automated Insulin Delivery system that does not require mealtime announcements-Effort will be led be Nudge BG founder and noted AID expert, Lane Desborough SAN DIEGO, CALIFORNIA / ACCESSWIRE / December 19, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to meet the needs of "almost-pumpers" with its user-friendly and affordable design, announced a licensing and partnership agreement with Nudge BG."We are very excited to partner with Modular Medical to bring the next g

    12/19/24 4:01:00 PM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    Modular Medical Announces Conference Call to Provide Business Update

    SAN DIEGO, CA / ACCESSWIRE / December 3, 2024 / Modular Medical, Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target all adult "almost-pumpers" with its user-friendly and affordable design, today announced it will hold a conference call and webcast on Thursday, December 5, 2024, at 10:00 a.m. Eastern Time to provide a business update.Conference Call and Webcast InformationDate: December 5, 2024Time: 10:00 a.m. Eastern Time (7:00 a.m. Pacific Time)Conference Call Number: 1-888-506-0062International Call Number: +1-973-528-0011Passcode: 494842Webcast: CLICK HEREFor those unable to

    12/3/24 8:00:00 AM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    Modular Medical Announces Pricing of $8.2 Million Public Offering

    SAN DIEGO, CA / ACCESSWIRE / November 21, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target all adult "almost-pumpers" with its user-friendly and affordable design, today announced that it has priced an underwritten public offering (the "offering") of 5,450,573 shares of its common stock. The offering was led by existing institutional investors, including Manchester Explorer, L.P., which is the largest shareholder of the Company and is managed by Jeb Besser, Modular Medical's Chief Executive Officer. The shares of common stock are being sold at a price t

    11/21/24 9:15:00 PM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    $MODD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Goldberg Jeff D

    4 - Modular Medical, Inc. (0001074871) (Issuer)

    10/3/25 6:21:17 AM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Director Vos Ellen O'Connor

    4 - Modular Medical, Inc. (0001074871) (Issuer)

    10/2/25 8:34:55 PM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Director Sheibley Philip Brent

    4 - Modular Medical, Inc. (0001074871) (Issuer)

    10/2/25 8:33:46 PM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    $MODD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Manchester Management Co Llc bought $1,299,997 worth of shares (677,082 units at $1.92) (SEC Form 4)

    4 - Modular Medical, Inc. (0001074871) (Issuer)

    3/24/25 9:34:00 PM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    Director by Deputization Manchester Management Co Llc bought $35,236 worth of shares (21,000 units at $1.68) (SEC Form 4)

    4 - Modular Medical, Inc. (0001074871) (Issuer)

    12/4/24 6:05:34 PM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    Director by Deputization Manchester Management Co Llc bought $168,950 worth of shares (100,000 units at $1.69) (SEC Form 4)

    4 - Modular Medical, Inc. (0001074871) (Issuer)

    11/29/24 10:00:09 AM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    $MODD
    SEC Filings

    View All

    Modular Medical Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

    8-K - Modular Medical, Inc. (0001074871) (Filer)

    9/23/25 8:30:42 AM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    SEC Form EFFECT filed by Modular Medical Inc.

    EFFECT - Modular Medical, Inc. (0001074871) (Filer)

    8/20/25 12:15:02 AM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    SEC Form POS AM filed by Modular Medical Inc.

    POS AM - Modular Medical, Inc. (0001074871) (Filer)

    8/13/25 5:29:22 PM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    $MODD
    Financials

    Live finance-specific insights

    View All

    Modular Medical Announces Conference Call to Provide Business Update

    SAN DIEGO, CA / ACCESSWIRE / December 3, 2024 / Modular Medical, Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target all adult "almost-pumpers" with its user-friendly and affordable design, today announced it will hold a conference call and webcast on Thursday, December 5, 2024, at 10:00 a.m. Eastern Time to provide a business update.Conference Call and Webcast InformationDate: December 5, 2024Time: 10:00 a.m. Eastern Time (7:00 a.m. Pacific Time)Conference Call Number: 1-888-506-0062International Call Number: +1-973-528-0011Passcode: 494842Webcast: CLICK HEREFor those unable to

    12/3/24 8:00:00 AM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    Modular Medical Announces Conference Call to Discuss FDA Clearance of the MODD1 Insulin Pump

    SAN DIEGO, CA / ACCESSWIRE / September 4, 2024 / Modular Medical, Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), an insulin delivery system technology company preparing to launch a market expansion product with a more accessible, easier to prescribe, and easier to pay for and live with technology, today announced it will hold a conference call and webcast tomorrow, Thursday, September 5, 2024, at 8:30 a.m. Eastern Time to discuss the U. S. Food and Drug Administration ("FDA") clearance of its MODD1 pump, as well as next steps and milestones.Conference Call and Webcast InformationDate: September 5, 2024Time: 8:30 a.m. Eastern Time (5:30 a.m. Pacific Time)Conference Call Number: 1-88

    9/4/24 6:57:00 PM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    Modular Medical Announces FDA Clearance of the MODD1 Insulin Pump

    MODD1 is a patch pump for ALL adults with Type 1 and Type 2 diabetesDesigned to be simpler and more affordable to expand access to diabetes technology for previously underserved communitiesCommercial availability expected in early 2025 SAN DIEGO, CA / ACCESSWIRE / September 4, 2024 / Modular Medical, Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), an insulin delivery system technology company preparing to launch a market expansion product with a more accessible, easier to prescribe, and easier to pay for and live with technology, today announced it has received U. S. Food and Drug Administration ("FDA") clearance to market and sell its MODD1 pump in the United States. With its comme

    9/4/24 4:30:00 PM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    $MODD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Modular Medical Inc.

    SC 13D/A - Modular Medical, Inc. (0001074871) (Subject)

    11/25/24 7:18:33 PM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by Modular Medical Inc.

    SC 13G - Modular Medical, Inc. (0001074871) (Subject)

    3/1/24 3:48:41 PM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13D/A filed by Modular Medical Inc. (Amendment)

    SC 13D/A - Modular Medical, Inc. (0001074871) (Subject)

    2/21/24 5:20:18 PM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    $MODD
    Leadership Updates

    Live Leadership Updates

    View All

    Modular Medical Announces Addition to the Russell Microcap(R) Index

    SAN DIEGO, CA / ACCESSWIRE / June 3, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical"), a development-stage, insulin delivery technology company seeking to launch the next generation of user-friendly and affordable insulin pump technology, today announced that it is set to join the Russell Microcap Index at the conclusion of the 2024 Russell indexes annual reconstitution, effective when the U.S. market opens on July 1, 2024.Membership in the Russell Microcap Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalizatio

    6/3/24 8:00:00 AM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    Modular Medical Announces Diabetes Industry Veteran Duane DeSisto Will Join the Board of Directors

    SAN DIEGO, CA / ACCESSWIRE / July 6, 2023 / Modular Medical, Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), a development stage insulin delivery technology company seeking to launch the next generation of easy to use and affordable insulin pump technology, today announced the appointment of medical device industry leader Duane DeSisto to its board of directors. Mr. DeSisto was previously President, CEO and Director of Insulet Corporation, developers of the groundbreaking OmniPod Insulin Management System, before retiring in 2014."Duane brings more than 25 years of experience in the medical device industry and is a visionary business leader credited with the launch and transformatio

    7/6/23 8:30:00 AM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    Modular Medical Appoints Kevin Schmid as Chief Operating Officer

    Schmid brings 40 years of experience in medical devices for drug delivery and diabetes management and a background in high-volume manufacturingSAN DIEGO, CA / ACCESSWIRE / July 26, 2022 / Modular Medical, Inc. (the "Company" or "Modular Medical")(NASDAQ:MODD) today announced that it has appointed industry veteran Kevin Schmid as its Chief Operating Officer. Mr. Schmid brings extensive operations and business development leadership experience in diabetes and drug delivery. As Vice President of Operations and Business Development at Insulet Corporation, he was instrumental in the development, manufacturing, and commercialization of wearable smart drug delivery pumps such as the Omnipod Diabete

    7/26/22 8:15:00 AM ET
    $MODD
    Medical/Dental Instruments
    Health Care